Trevi Therapeutics (TRVI) Stock Forecast for 2024–2028. Sell or Buy Prediction







Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

Trevi Therapeutics (TRVI) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 20, 2024 (06:04)

Sector: Healthcare

The share price of Trevi Therapeutics, Inc. (TRVI) now

Latest session on the 19th of April for
Trevi Therapeutics, Inc. is positive
Trading Volume: 144472
Open: 2.66 /  High: 2.92 /  Low: 2.59
What analysts predict: $7.33
52-week High/Low: $4 / $0.97

50/200 Day Moving Average: $2.83 / $2.062

This figure corresponds to the Average Price over the previous 50/200 days. For Trevi Therapeutics stocks, the 50-day moving average is the support level today.

For Trevi Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in Trevi Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Trevi Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Trevi Therapeutics share be worth in 2024 - 2028?

When should I take profit in Trevi Therapeutics stock? When should I record a loss on Trevi Therapeutics stock? What are analysts' forecasts for Trevi Therapeutics stock? What is the future of Trevi Therapeutics stock? We forecast Trevi Therapeutics stock performance using neural networks based on historical data on Trevi Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Trevi Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Trevi Therapeutics shares. This happens once a day.


Historical and forecast chart of Trevi Therapeutics stock

The chart below shows the historical price of Trevi Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Trevi Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Trevi Therapeutics Inc. is a clinical biopharmaceutical company focused on the development and commercialization of Nalbuphine ER for the treatment of neurologically mediated conditions. The company is developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and levodopa-induced dyskinesia (LD), in patients with Parkinson’s disease. The company is conducting phase 2b/3 clinical trials for nalbuphine ER. The company has also initiated a phase 1b clinical trial in patients with chronic liver disease to evaluate the safety, pharmacokinetics, and antipruritic effect of nalbuphine ER in this population. The Company’s nalbuphine development programs for ER include the Chronic Pruritus Program, the Nodular Pruritus Program, the Chronic Liver Disease Pruritus Program, and the Uremic Pruritus Program.

Trevi Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 22 2.56 2.43 2.82 16.12
Apr 23 2.51 2.21 2.73 23.31
Apr 24 2.33 2.13 2.43 14.13
Apr 25 2.39 2.15 2.60 21.18
Apr 26 2.70 2.47 2.85 15.25
Apr 27 2.87 2.72 3.17 16.62
Apr 28 2.91 2.71 3.20 18.21
Apr 29 3.12 2.79 3.24 16.28
Apr 30 2.81 2.62 3.01 14.94
May 01 2.49 2.22 2.66 19.67
May 02 2.34 2.24 2.53 13.02
May 03 2.44 2.18 2.69 23.17
May 04 2.45 2.34 2.60 11.13
May 05 2.35 2.08 2.50 20.55
May 06 2.46 2.26 2.62 15.64
May 07 2.35 2.21 2.51 13.52
May 08 2.34 2.23 2.59 16.07
May 09 2.42 2.20 2.51 13.82
May 10 2.51 2.26 2.81 24.31
May 11 2.15 1.89 2.24 18.58
May 12 2.08 1.89 2.22 17.50
May 13 1.87 1.66 2.02 21.43
May 14 2.14 1.96 2.23 13.59
May 15 2.18 1.94 2.42 24.55
May 16 2.07 2.00 2.29 14.40
May 17 2.28 2.08 2.46 18.27
May 18 2.44 2.27 2.57 13.23
May 19 2.15 1.89 2.31 22.16
May 20 2.02 1.91 2.24 17.31
May 21 1.87 1.65 1.93 16.42

Trevi Therapeutics Daily Price Targets


Trevi Therapeutics Stock Forecast 04-22-2024.

Forecast target price for 04-22-2024: $2.56.
Negative dynamics for Trevi Therapeutics shares will prevail with possible volatility of 13.884%.
Pessimistic target level: 2.43
Optimistic target level: 2.82

Trevi Therapeutics Stock Forecast 04-23-2024.

Forecast target price for 04-23-2024: $2.51.
Negative dynamics for Trevi Therapeutics shares will prevail with possible volatility of 18.905%.
Pessimistic target level: 2.21
Optimistic target level: 2.73

Trevi Therapeutics Stock Forecast 04-24-2024.

Forecast target price for 04-24-2024: $2.33.
Negative dynamics for Trevi Therapeutics shares will prevail with possible volatility of 12.380%.
Pessimistic target level: 2.13
Optimistic target level: 2.43

Trevi Therapeutics Stock Forecast 04-25-2024.

Forecast target price for 04-25-2024: $2.39.
Positive dynamics for Trevi Therapeutics shares will prevail with possible volatility of 17.477%.
Pessimistic target level: 2.15
Optimistic target level: 2.60

Trevi Therapeutics Stock Forecast 04-26-2024.

Forecast target price for 04-26-2024: $2.70.
Positive dynamics for Trevi Therapeutics shares will prevail with possible volatility of 13.235%.
Pessimistic target level: 2.47
Optimistic target level: 2.85

Trevi Therapeutics Stock Forecast 04-27-2024.

Forecast target price for 04-27-2024: $2.87.
Positive dynamics for Trevi Therapeutics shares will prevail with possible volatility of 14.253%.
Pessimistic target level: 2.72
Optimistic target level: 3.17

TRVI (TRVI) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 3.12 2.85 3.87 26.37
Jun. 3.10 2.90 3.74 22.62
Jul. 3.48 2.91 4.07 28.51
Aug. 3.10 2.44 3.46 29.54
Sep. 2.27 1.87 2.46 24.08
Oct. 2.72 2.07 3.12 33.48
Nov. 2.96 2.50 3.24 22.72
Dec. 3.16 2.66 3.78 29.62

Trevi Therapeutics forecast for this year


Trevi Therapeutics Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $3.11997. Pessimistic: $2.85. Optimistic: $3.87


Trevi Therapeutics Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $3.10125. Pessimistic: $2.90. Optimistic: $3.74


Trevi Therapeutics Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $3.4827. Pessimistic: $2.91. Optimistic: $4.07


Trevi Therapeutics Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $3.09612. Pessimistic: $2.44. Optimistic: $3.46


Trevi Therapeutics Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $2.26946. Pessimistic: $1.87. Optimistic: $2.46


Trevi Therapeutics Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $2.71881. Pessimistic: $2.07. Optimistic: $3.12


Trevi Therapeutics Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $2.95535. Pessimistic: $2.50. Optimistic: $3.24


Trevi Therapeutics Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $3.15927. Pessimistic: $2.66. Optimistic: $3.78



Trevi Therapeutics (TRVI) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 3.21 2.75 3.84 28.30
Feb 2.67 2.50 3.14 20.39
Mar 3.02 2.51 3.53 28.77
Apr 2.86 2.66 3.10 14.11
May 2.74 2.35 3.06 23.10
Jun 2.63 2.24 3.21 30.27
Jul 2.53 2.38 2.94 19.10
Aug 2.72 2.18 2.96 26.42
Sep 3.10 2.59 3.36 22.97
Oct 2.80 2.29 3.32 30.94
Nov 2.99 2.47 3.66 32.57
Dec 3.17 2.72 3.55 23.30

Trevi Therapeutics (TRVI) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.49 2.16 2.81 23.18
Feb 2.48 2.27 2.67 15.07
Mar 2.40 2.09 2.86 26.75
Apr 2.15 1.72 2.32 25.60
May 2.07 1.74 2.43 28.44
Jun 2.02 1.80 2.16 16.32
Jul 2.22 1.92 2.72 29.14
Aug 1.66 1.54 1.87 17.58
Sep 1.69 1.48 2.00 25.87
Oct 1.71 1.40 2.06 32.22
Nov 1.37 1.10 1.54 28.85
Dec 1.59 1.42 1.96 27.61

Trevi Therapeutics (TRVI) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 1.88 1.56 2.09 25.18
Feb 1.61 1.34 1.79 25.31
Mar 1.93 1.63 2.38 31.77
Apr 1.69 1.44 1.86 22.66
May 1.94 1.83 2.26 19.31
Jun 2.13 1.91 2.44 21.77
Jul 2.03 1.89 2.31 18.45
Aug 2.04 1.72 2.51 31.44
Sep 1.94 1.66 2.28 27.27
Oct 1.67 1.52 1.86 18.09
Nov 1.92 1.55 2.13 27.20
Dec 2.36 1.95 2.79 29.92

Trevi Therapeutics (TRVI) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 2.73 2.49 3.04 18.04
Feb 2.34 1.79 2.80 36.31
Mar 2.21 1.78 2.70 34.29
Apr 2.62 2.19 2.85 23.39
May 3.26 2.54 3.76 32.52
Jun 3.58 3.26 4.00 18.48
Jul 3.14 2.47 3.68 32.96
Aug 2.73 2.09 3.38 38.08
Sep 2.90 2.71 3.14 13.56
Oct 2.43 2.15 2.74 21.58
Nov 1.76 1.34 1.89 29.02
Dec 1.51 1.24 1.65 24.98

Trevi Therapeutics information and performance

Trevi Therapeutics Address

195 CHURCH STREET, 14TH FLOOR, NEW HAVEN, CT, US

Market Capitalization: 177 917 000 $

Market capitalization of the Trevi Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of TRVI shares in the company outstanding by the market price of one share.

EBITDA: -33 800 000 $

EBITDA of Trevi Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.29

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -4.189

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 68960000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.